Membranous nephropathy secondary to very early-onset inflammatory bowel disease in a 3-year-old boy: case report.

IF 1 Q4 UROLOGY & NEPHROLOGY
Shuhei Aoyama, Tomohiko Yamamura, Tomoko Horinouchi, Yuka Kimura, Yuta Inoki, Nana Sakakibara, China Nagano, Shingo Ishimori, Yasuyuki Kameoka, Keisuke Kajihara, Harunori Miyauchi, Yuna Ku, Haruka Miyazaki, Norihiro Okamoto, Norishige Yoshikawa, Kandai Nozu
{"title":"Membranous nephropathy secondary to very early-onset inflammatory bowel disease in a 3-year-old boy: case report.","authors":"Shuhei Aoyama, Tomohiko Yamamura, Tomoko Horinouchi, Yuka Kimura, Yuta Inoki, Nana Sakakibara, China Nagano, Shingo Ishimori, Yasuyuki Kameoka, Keisuke Kajihara, Harunori Miyauchi, Yuna Ku, Haruka Miyazaki, Norihiro Okamoto, Norishige Yoshikawa, Kandai Nozu","doi":"10.1007/s13730-026-01116-3","DOIUrl":null,"url":null,"abstract":"<p><p>Membranous nephropathy (MN) is uncommon in children overall, but secondary MN is relatively common in younger children. Inflammatory bowel disease (IBD) can be complicated by kidney disease, but IBD complicated by MN is rarely reported. A 3-year-old boy diagnosed with very early onset IBD (VEO-IBD) a year earlier was incidentally found to have proteinuria via urine screening system. Laboratory tests revealed nephrotic syndrome with microscopic hematuria and signs of ongoing inflammation associated with IBD activity. Kidney biopsy showed mesangial cell proliferation and dense subepithelial immune complex deposits, along with negative PLA2R staining, which supported a diagnosis of secondary MN. Oral steroid therapy was initiated for its potential benefit for both nephrotic syndrome and the underlying VEO-IBD. As a result, four months later, proteinuria and hematuria had resolved, and kidney function remained stable. This is the youngest reported patient with MN associated with IBD. Routine urinalysis is suggested by this case to be useful for detecting kidney complications of IBD, including MN. Moreover, steroid therapy is likely to be useful for MN secondary to IBD. Our report suggests that potential kidney complications should also be considered in patients with VEO-IBD.</p>","PeriodicalId":9697,"journal":{"name":"CEN Case Reports","volume":"15 4","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2026-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13280327/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CEN Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13730-026-01116-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Membranous nephropathy (MN) is uncommon in children overall, but secondary MN is relatively common in younger children. Inflammatory bowel disease (IBD) can be complicated by kidney disease, but IBD complicated by MN is rarely reported. A 3-year-old boy diagnosed with very early onset IBD (VEO-IBD) a year earlier was incidentally found to have proteinuria via urine screening system. Laboratory tests revealed nephrotic syndrome with microscopic hematuria and signs of ongoing inflammation associated with IBD activity. Kidney biopsy showed mesangial cell proliferation and dense subepithelial immune complex deposits, along with negative PLA2R staining, which supported a diagnosis of secondary MN. Oral steroid therapy was initiated for its potential benefit for both nephrotic syndrome and the underlying VEO-IBD. As a result, four months later, proteinuria and hematuria had resolved, and kidney function remained stable. This is the youngest reported patient with MN associated with IBD. Routine urinalysis is suggested by this case to be useful for detecting kidney complications of IBD, including MN. Moreover, steroid therapy is likely to be useful for MN secondary to IBD. Our report suggests that potential kidney complications should also be considered in patients with VEO-IBD.

膜性肾病继发于非常早发性炎症性肠病1例3岁男孩。
膜性肾病(MN)在儿童中并不常见,但继发性MN在年幼儿童中相对常见。炎症性肠病(IBD)可并发肾脏疾病,但IBD并发MN的报道很少。一年前被诊断为极早发性IBD (VEO-IBD)的3岁男孩偶然通过尿液筛查系统发现有蛋白尿。实验室检查显示肾病综合征伴有显微镜下血尿和与IBD活动相关的持续炎症迹象。肾活检显示系膜细胞增生和密集的上皮下免疫复合物沉积,PLA2R染色呈阴性,支持继发性MN的诊断。口服类固醇治疗对肾病综合征和潜在的VEO-IBD都有潜在的益处。结果,4个月后,蛋白尿和血尿消失,肾功能保持稳定。这是最年轻的合并IBD的MN患者。本病例提示常规尿分析可用于检测IBD的肾脏并发症,包括MN。此外,类固醇治疗可能对IBD继发的MN有用。我们的报告表明,VEO-IBD患者也应考虑潜在的肾脏并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CEN Case Reports
CEN Case Reports UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
80
期刊介绍: Clinical and Experimental Nephrology (CEN) Case Reports is a peer-reviewed online-only journal, officially published biannually by the Japanese Society of Nephrology (JSN).  The journal publishes original case reports in nephrology and related areas.  The purpose of CEN Case Reports is to provide clinicians and researchers with a forum in which to disseminate their personal experience to a wide readership and to review interesting cases encountered by colleagues all over the world, from whom contributions are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书